FLAG+Ida With G-CSF Priming for Patients Younger Than 60 Years With Resistant AML
Clinical trial NCT00559221 · UNKNOWN
Trial details
- NCT number
- NCT00559221
- Sponsor
- Cooperative Study Group A for Hematology
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-12-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.